Motohiko Tanaka

Interferon Therapy Reduces the Risk for Hepatocellular Carcinoma: National Surveillance Program of Cirrhotic and Noncirrhotic Patients with Chronic Hepatitis C in Japan

Haruhiko Yoshida, Yasushi Shiratori, Mitsuhiko Moriyama et al. · Annals of Internal Medicine · 1999 · 1.1K citations

Cys34-Cysteinylated Human Serum Albumin Is a Sensitive Plasma Marker in Oxidative Stress-Related Chronic Diseases

Kohei Nagumo, Motohiko Tanaka, Victor Tuan Giam Chuang et al. · PLoS ONE · 2014 · 193 citations · Full text

Bcaa Supplementation, Immunology, Oxidative Stress +20

Coinfection of hepatitis C virus in patients with chronic hepatitis B infection

Shinjiro Sato, Shigetoshi Fujiyama, Motohiko Tanaka et al. · Journal of Hepatology · 1994 · 155 citations

Hepatitis D, Viral Persistence, Hepatology +8

Risk factors for development of hepatocellular carcinoma in patients with chronic hepatitis C after sustained response to interferon

Masafumi Ikeda, Shigetoshi Fujiyama, Motohiko Tanaka et al. · Journal of Gastroenterology · 2005 · 131 citations

Hepatology, Hepatitis C, Viral Hepatitis +13

Transcatheter Arterial Chemotherapy with and without Embolization in Patients with Hepatocellular Carcinoma

Masafumi Ikeda, Seishi Maeda, Junji Shibata et al. · Oncology · 2004 · 88 citations